Latest News about fda
Recent news which mentions fda
Regulatory Setback For Minerva Neurosciences' Schizophrenia Treatment Candidate, FDA Asks For More Data
February 27, 2024
From Benzinga
New York Attorney General Urges FDA Action On Widely Used Asthma Drug's Concerns Over Pediatric Safety
February 26, 2024
From Benzinga
Why Is Generic Drugs Player Teva Pharma Stock Trading Higher Today?
February 26, 2024
From Benzinga
Do Not Use Smartwatches, Rings That Claim To Measure Blood Sugar Without Needles, FDA Says
February 22, 2024
From Benzinga
United Therapeutics' Challenges FDA Over Liquidia's Drug Approval Process, Clocks Strong Q4 Earnings
February 21, 2024
From Benzinga
FDA Approves Johnson & Johnson's Reduced Tecvayli Dosing In Pretreated Multiple Myeloma Patients
February 21, 2024
From Benzinga
FDA Gathers Public Social Media Data To Better Understand Cannabis Users As Part Of Its Effort Toward Rescheduling Marijuana
February 20, 2024
From Benzinga
ARS Pharma Readies Data In Response To FDA's Rejection For Its EpiPen Alternative For Severe Allergic Reactions
February 20, 2024
From Benzinga
Why Is Inflammatory Disease/Oncology-Focused RAPT Therapeutics Shares Tumbling Today?
February 20, 2024
From Benzinga
Why AstraZeneca Stock Is Trading Higher Tuesday
February 20, 2024
From Benzinga
Politics Over Public Health? FDA Head Expresses Concern Over Biden's Delay Of Menthol Cigarette Ban
February 17, 2024
Tickers
NEWS
From Benzinga
Cybin Inc. Q3 Earnings: Clinical Advances Amid Financial Loss
February 16, 2024
From Benzinga
FDA Fast-Tracks Review Of Sarepta's Groundbreaking Muscular Dystrophy Treatment With $1B Market In Sight
February 16, 2024
From Benzinga
Why Is Gilead Sciences Stock Trading Lower Today?
February 16, 2024
From Benzinga
Marjorie Taylor Greene Faces Democratic Criticism Over 'Vulgarity' And 'Conspiracy' In Vaccine Hearing
February 16, 2024
Tickers
NEWS
From Benzinga
Cardiology's Quantum Leap: FDA's Advisory Panel Gives Thumbs Up To Abbott's Minimally Invasive Heart Valve Repair Device
February 14, 2024
From Benzinga
Substance Use Disorder Company Narrows Q2 Net Loss, Reports Progress On Cannabinoid Intoxication Drug
February 14, 2024
From Benzinga
US Police Seizures Of Psychedelic Mushrooms Increased In Recent Years, New Study Finds
February 12, 2024
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.